Sort by
Refine Your Search
-
Employer
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Institute of Nuclear Chemistry and Technology
- Institute of Physical Chemistry, Polish Academy of Sciences
- International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences
- International Institute of Molecular and Cell Biology in Warsaw
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
- Nencki Institute of Experimental Biology
-
Field
-
of the results of basic research, e.g. to develop the premise of new therapies, diagnostic methods, discover new therapeutic objectives or to identify molecules with desirable properties so that they can be
-
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences | Poland | about 1 month ago
for the position. The successful Candidate, under a supervision of the project leader, will work on developing active nanocarriers based on nanoparticles for oncological and neuroprotective therapy. The project
-
achieved with more selective therapies targeting biomarkers typical for a cancer cell, still a large part of patients cannot be cured. Incomplete eradication of residual tumor cells and acquired drug
-
WORDS: neurodegenerative diseases, oligonucleotides in therapy, microRNA, oxidative stress, neuronal cell cultures Principal Investigator: Agnieszka Fiszer, PhD, professor of IBCH PAS Website
-
, safety, gene therapy, DNA repair Principal Investigator: Marta Olejniczak, PhD, professor of IBCH PAS Research topic: “Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease
-
: microsatellite sequences, CAG repeats, DNA repair, neurodegenerative diseases, gene therapy Research topic: Investigation of the mechanisms of short tandem repeats instability Principal Investigator: Marta
-
International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences | Poland | 2 months ago
to develop new tools for safer and more effective surgical interventions, new therapies for eye diseases, and diagnostic methods to improve prognosis and restore vision. The main technology to be developed
-
compulsive alcohol seeking and consumption, hallmarks of addiction, are still unknown. Thus the successful therapy of addiction is still missing. In the current project we shall investigate the role of the CA1
-
for studying basic mechanisms of angiogenesis in healthy and diseased tissues as well as for future applications in personalized cancer therapies. Requirements Research FieldBiological sciences